United States· US:82715-107_f41b33bc-f8f8-4623-b52c-fc6d701671d5
GR LONGSTAY Matte Face Powder SPF 15
A octinoxate product containing octinoxate, registered in United States by ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI. The same ATC class is registered in 2 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Octinoxate is registered in 2 of 19 countries.
Countries holding a registration under ATC D02BA02 (octinoxate), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 1 of them publish a price we can compare per daily dose
Octinoxate · ATC D02BA02
2 / 19 countries
- Canada
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OCTINOXATE
- Manufacturer
- ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI
- Country
- United States (US)
- ATC code
- D02BA02
- ATC class
- Octinoxate
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 20
- ndc1182715107011 CONTAINER in 1 CARTON (82715-107-01) / 12.7 g in 1 CONTAINER
- ndc1182715107021 CONTAINER in 1 CARTON (82715-107-02) / 12.7 g in 1 CONTAINER
- ndc1182715107031 CONTAINER in 1 CARTON (82715-107-03) / 12.7 g in 1 CONTAINER
- ndc1182715107041 CONTAINER in 1 CARTON (82715-107-04) / 12.7 g in 1 CONTAINER
- ndc1182715107051 CONTAINER in 1 CARTON (82715-107-05) / 12.7 g in 1 CONTAINER
- ndc1182715107061 CONTAINER in 1 CARTON (82715-107-06) / 12.7 g in 1 CONTAINER
- ndc1182715107071 CONTAINER in 1 CARTON (82715-107-07) / 12.7 g in 1 CONTAINER
- ndc1182715107081 CONTAINER in 1 CARTON (82715-107-08) / 12.7 g in 1 CONTAINER
- ndc1182715107091 CONTAINER in 1 CARTON (82715-107-09) / 12.7 g in 1 CONTAINER
- ndc1182715107101 CONTAINER in 1 CARTON (82715-107-10) / 12.7 g in 1 CONTAINER
- ndc1182715-107-01
- ndc1182715-107-02
- ndc1182715-107-03
- ndc1182715-107-04
- ndc1182715-107-05
- ndc1182715-107-06
- ndc1182715-107-07
- ndc1182715-107-08
- ndc1182715-107-09
- ndc1182715-107-10
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Octinoxate in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f8e9c389-9402-4efa-a839-32b5bed816e7 GET /v1/drugs/f8e9c389-9402-4efa-a839-32b5bed816e7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "1.995",
"substance": "OCTINOXATE",
"productndc": "82715-107",
"dosage_form": "POWDER",
"dea_schedule": null,
"strength_unit": "g/100g",
"application_number": "M020",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about octinoxate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.